We are live on ! Find out more
EP

Elkfork Partners Portfolio holdings

AUM $4.11B
1-Year Est. Return 5.26%
This Fund
S&P 500
This Quarter Est. Return
+14.47%
1 Year Est. Return
+5.26%
3 Year Est. Return
+52.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.99B
AUM Growth
+$441M
Cap. Flow
-$32.5M
Cap. Flow %
-0.81%
Top 10 Hldgs %
25.17%
Holding
1,061
New
46
Increased
392
Reduced
202
Closed
28

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$15.3M
2
COF icon
Capital One
COF
+$11.2M
3
ETN icon
Eaton
ETN
+$10.3M
4
FTNT icon
Fortinet
FTNT
+$10M
5
BIIB icon
Biogen
BIIB
+$8.07M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$19.7M
2
BA icon
Boeing
BA
+$17.9M
3
HUM icon
Humana
HUM
+$15.2M
4
CI icon
Cigna
CI
+$14.8M
5
ALL icon
Allstate
ALL
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 20.19%
2 Financials 15.59%
3 Consumer Discretionary 13.07%
4 Healthcare 11.45%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BB icon
1001
BlackBerry
BB
$4.98B
$31K ﹤0.01%
3,128
– –
CONN
1002
DELISTED
Conn's Inc.
CONN
$31K ﹤0.01%
+1,342
New +$28.9K
ARRY
1003
DELISTED
Array Biopharma Inc
ARRY
$31K ﹤0.01%
1,258
+850
+208% +$17.7K
INXN
1004
DELISTED
Interxion Holding N.V.
INXN
$30K ﹤0.01%
442
– –
DNTH icon
1005
Dianthus Therapeutics
DNTH
$5.84B
$28K ﹤0.01%
105
– –
QTWO icon
1006
Q2 Holdings
QTWO
$3.8B
$28K ﹤0.01%
408
– –
COUP
1007
DELISTED
Coupa Software Incorporated
COUP
$28K ﹤0.01%
308
– –
VRNT
1008
DELISTED
Verint Systems
VRNT
$27K ﹤0.01%
879
+55
+7% +$1.4K
INSM icon
1009
Insmed
INSM
$21.4B
$26K ﹤0.01%
+880
New +$22.8K
KGC icon
1010
Kinross Gold
KGC
$27.4B
$25K ﹤0.01%
7,446
– –
NUAN
1011
DELISTED
Nuance Communications, Inc.
NUAN
$25K ﹤0.01%
1,682
+65
+4% +$901
BMRN icon
1012
BioMarin Pharmaceuticals
BMRN
$11.6B
$24K ﹤0.01%
+272
New +$25.2K
SRPT icon
1013
Sarepta Therapeutics
SRPT
$1.57B
$24K ﹤0.01%
198
+22
+13% +$2.83K
PCTY icon
1014
Paylocity
PCTY
$7.38B
$22K ﹤0.01%
242
+22
+10% +$1.71K
DNLI icon
1015
Denali Therapeutics
DNLI
$3.65B
$21K ﹤0.01%
918
– –
TBHC
1016
DELISTED
The Brand House Collective
TBHC
$21K ﹤0.01%
3,026
– –
ALTR
1017
DELISTED
Altair Engineering Inc
ALTR
$21K ﹤0.01%
560
+28
+5% +$942
SNDX icon
1018
Syndax Pharmaceuticals
SNDX
$1.69B
$19K ﹤0.01%
3,584
-700
-16% -$3.99K
SLP icon
1019
Simulations Plus
SLP
$369M
$18K ﹤0.01%
+868
New +$17.4K
MRTX
1020
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$18K ﹤0.01%
+242
New +$16.5K
OBSV
1021
DELISTED
ObsEva SA Ordinary Shares
OBSV
$18K ﹤0.01%
1,386
– –
ARNA
1022
DELISTED
Arena Pharmaceuticals Inc
ARNA
$18K ﹤0.01%
408
– –
BOX icon
1023
Box
BOX
$4.37B
$16K ﹤0.01%
836
+44
+6% +$912
ECOM
1024
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$16K ﹤0.01%
1,298
+66
+5% +$788
SAP icon
1025
SAP
SAP
$212B
$15K ﹤0.01%
132
– –
39 40
41
42 43

Similar funds

GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return

Elkfork Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Elkfork Partners held 1,061 positions worth $3.99B, up 12% from $3.55B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Elkfork Partners's Q1 2019 filing shows 46 new, 392 increased, 202 reduced and 28 closed positions. Its largest new stake was Celanese: 38,742 shares worth $3.82M. The largest sale was Celgene Corp, an estimated $19.7M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Elkfork Partners's largest Q1 2019 buy was Celanese: 38,742 shares worth $3.82M.
  • Elkfork Partners added most to Microsoft in Q1 2019, an estimated $15.3M increase.
  • Elkfork Partners's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $19.7M.
  • Elkfork Partners fully exited VICI Properties in Q1 2019, selling an estimated $2.23M.
  • Elkfork Partners's ten largest holdings make up 25% of its $3.99B portfolio in Q1 2019.
  • Elkfork Partners opened 46 new positions and closed 28 in Q1 2019.
  • Elkfork Partners's portfolio value rose 12% quarter-over-quarter to $3.99B.

Based on Elkfork Partners's 13F filing for Q1 2019, filed 13 May 2019.